1. The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib
   Aldo Di Vito et al, 2023, Pharmacology & Therapeutics CrossRef
2. A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
   Jame Abraham et al, 2009, Clinical Cancer Research CrossRef
3. c-Kit/PDGFRA Gene Status Alterations Possibly Related to Primary Imatinib Resistance in Gastrointestinal Stromal Tumors
   Francesca="C"> Miselli et al, 2007, Clinical Cancer Research CrossRef
4. Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
   Michael C. Heinrich et al, 2008, Journal of Clinical Oncology CrossRef